SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing renewed engagement as investors speculate on potential M&A moves and monitor Michael Burrys increased stake in the company. The community remains divided, with some users pushing for a 'No' vote on the CEO's compensation package while others focus on long-term value and potential short-squeeze dynamics.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is attracting significant investor interest as the community anticipates major catalysts, specifically the finalization of the crypto.com/us partnership and upcoming product launches in the U.S. prediction market space. While bulls highlight high insider ownership and potential for a breakout, active discussions remain divided between those viewing the recent price consolidation as a strategic buying opportunity and skeptics concerned about the timeline for definitive news and regulatory hurdles.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing heavy volume and volatility as investors weigh the potential impact of Amazon's acquisition of Globalstar against the upcoming launch of the BlueBird 7 satellite on Blue Origins New Glenn rocket. The community remains deeply divided, with bulls pointing to the company's patented D2D technology and strategic institutional backing as key long-term catalysts, while skeptics focus on competitive pressure and the market's recent reaction to broader sector news.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to a combination of new high-profile partnerships, including an innovation center agreement with the University of Cambridge, and ongoing speculation regarding its role in national defense and AI-driven quantum infrastructure. While retail investors remain divided between optimistic long-term accumulation and skepticism over dilution and cash burn, the stock is seeing significant options activity and active debates regarding the company's positioning within the broader quantum super-cycle.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing significant downward pressure as investors react to underwhelming delivery figures and ongoing operational challenges, including supply chain disruptions and product recalls. Despite a new buy rating from Citigroup, the community remains deeply divided, with many participants expressing concerns over potential further share dilution and the company's long-term financial viability.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently a focal point for investors as its fuel cell technology becomes central to the AI data center infrastructure race, causing significant price volatility and heavy trading volume. The community is actively debating the stock's long-term potential as a critical power provider versus concerns about valuation, recent analyst target adjustments, and the broader impact of energy sector headlines.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending after the company announced the immediate termination of its standby equity purchase agreement with Yorkville, a move long-awaited by investors concerned about potential dilution. The community is actively debating the significance of this development, with bulls viewing it as a critical catalyst for a trend reversal and potential short squeeze, while some remain cautious about the stock's long-term recovery.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is experiencing extreme volatility as retail investors and algorithms react to a mix of aggressive short-interest, speculative trading in the quantum sector, and concerns over the company's ability to hit commercial milestones. The community remains deeply polarized, with bulls pointing to long-term sector potential and technical breakthroughs, while bears focus on the disconnect between high valuations and minimal revenue growth.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is generating significant debate as investors weigh the company's dual-platform capabilities and defense sector partnerships against intense competitive pressure from industry heavyweights. The community remains polarized, with many retail traders actively discussing the potential for a rebound driven by institutional accumulation while critics point to concerns over valuation and the company's path to profitability.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market activity as rumors of an acquisition by Amazon or SpaceX to bolster satellite broadband capabilities drive widespread speculation. Community sentiment is overwhelmingly bullish, with long-term shareholders debating the massive strategic value of the company's globally harmonized spectrum and the complexities surrounding existing partnerships, leading many to dismiss current price valuations as far below the potential bidding war floor.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Penny Stocks To Watch Now - November 17th

Leap Therapeutics, Autonomix Medical, Cypherpunk Technologies, Annovis Bio, and Datavault AI are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are...

Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why

Autonomix Medical, Inc. (AMIX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech

Monte Rosa Therapeutics Inc. (<a class="mention" data-mention="$GLUE" data-symbol-id="GLUE" href="https://stocktwits.com/symbol/GLUE" target="_blank">$GLUE</a>)<figure class="image"><a href="https://stocktwits.com/symbol/GLUE"><img style="aspect-ratio:1284/287;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_28_132438_e581646ba1.png" alt="Screenshot 2024-10-28 132438.png" width="1284" height="287"></a><figcaption>Monte Rosa Therapeutic's sentiment meter as of 1:25 p.m. ET on Oct. 28, 2024 | Source: Stocktwits</figcaption></figure>Shares of Monte Rosa Therapeutics surged over 130% on Monday, reaching a two-year high of $12.15 after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/glue-stock-enthralls-retail-with-novartis-licensing-deal/cJ2rnM9RJW">announcing an exclusive global licensing agreement with Novartis AG ($NVS).</a>&nbsp;The collaboration focuses on developing innovative treatments for immune-related conditions, particularly MRT-6160, an oral drug designed to inhibit the degradation of VAV1, a key signaling protein for T and B cell receptors.&nbsp;As part of the agreement, Novartis will pay $150 million upfront for exclusive worldwide rights to MRT-6160 and other VAV1-targeting molecular glues, with Monte Rosa eligible for up to $2.1 billion in milestones and tiered royalties on international sales.Retail sentiment on Stocktwits surged to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.Evoke Pharma Inc. (<a class="mention" data-mention="$EVOK" data-symbol-id="EVOK" href="https://stocktwits.com/symbol/EVOK" target="_blank">$EVOK</a>)<figure class="image"><a href="https://stocktwits.com/symbol/EVOK"><img style="aspect-ratio:1282/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_28_132459_473ee74b09.png" alt="Screenshot 2024-10-28 132459.png" width="1282" height="282"></a><figcaption>Evoke Pharma's sentiment meter as of 1:25 p.m. ET on Oct. 28, 2024 | Source: Stocktwits</figcaption></figure>Evoke Pharma’s shares were up over 30% on Monday following its presentation of&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/evoke-pharma-stock-spikes-higher-on-study-data/cJ2rllaRJO">positive data for its lead drug</a>, Gimoti, as a treatment option for diabetes gastroparesis.The company ranked among the top 10 trending stocks on Stocktwits, secured the second spot for most watched, and was listed in the top 20 most active stocks&nbsp;on Monday afternoon.Evoke Pharma and its partner, Eversana, found that patients using Gimoti, a nasal version of metoclopramide, experienced significant improvements compared to those using the oral formulation. Patients who received the nasal treatment had reduced healthcare resource use and fewer healthcare visits.Retail sentiment on Stocktwits surged into ‘extremely bullish’ territory (97/100) with ‘extremely high’ (97/100) message volume.Autonomix Medical Inc. (<a class="mention" data-mention="$AMIX" data-symbol-id="AMIX" href="https://stocktwits.com/symbol/AMIX" target="_blank">$AMIX</a>)<figure class="image"><a href="https://stocktwits.com/symbol/AMIX"><img style="aspect-ratio:1271/277;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_28_132518_8d6392edf1.png" alt="Screenshot 2024-10-28 132518.png" width="1271" height="277"></a><figcaption>Autonomix Medical's sentiment meter as of 1:25 p.m. ET on Oct. 28, 2024 | Source: Stocktwits</figcaption></figure>Shares of Autonomix skyrocketed by more than 90% on Monday morning following the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/autonomix-stock-rallies-on-strong-trial-results/cJ2rlAHRJf">announcement of positive results from its clinical trial</a> aimed at alleviating pain in pancreatic cancer patients.&nbsp;The stock became the second-highest trending on Stocktwits, just behind Trump Media &amp; Technology Group Corp. ($DJT), and was listed among the top 10 most watched stocks of the day.Retail sentiment on Stocktwits surged to ‘extremely bullish’ (97/100) with chatter escalating into ‘extremely high’ (97/100) territory.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/mstr-stock-hits-all-time-high-as-btc-crosses-68000/cJ2rj2hRJ9">MicroStrategy’s Bitcoin Holdings Drive Historic High: Retail Unfazed</a>

Retail is most bullish on these stocks today | Source: Pexels

Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention

Retail sentiment was particularly strong for healthcare stocks today, as Monte Rosa, Autonomix, and Evoke Pharma each announced positive developments regarding their respective innovations.

Equity

Retail sentiment was particularly strong for healthcare stocks today, as Monte Rosa, Autonomix, and Evoke Pharma each announced positive developments regarding their respective innovations.


Shares of Autonomix Medical Inc. (<a class="mention" data-mention="$AMIX" data-symbol-id="AMIX" href="https://stocktwits.com/symbol/AMIX" target="_blank">$AMIX</a>) soared by over 90% on Monday morning after the company reported positive results from its clinical trial focused on managing pain in pancreatic cancer patients.It ranked as the second-highest trending stock on Stocktwits on Monday, trailing only Trump Media &amp; Technology Group Corp. (<a class="mention" data-mention="$DJT" data-symbol-id="DJT" href="https://stocktwits.com/symbol/DJT" target="_blank">$DJT</a>), and was also among the top 10 most watched stocks.The trial employs an innovative technique to target and ablate the nerves responsible for pain in late-stage pancreatic cancer patients.&nbsp;Early results from the first five participants, known as the "lead-in" cohort, have been promising, with all reporting significant pain relief after the procedure.Set to conclude by the end of 2024, the trial seeks to provide an alternative to opioid pain management, which poses risks of addiction and overdose.Autonomix's technology features a catheter-based microchip sensing array antenna, which can detect neural signals more sensitively than current technologies. This precision-guided approach is intended to diagnose and treat issues related to the peripheral nervous system.To further enhance the trial, the company plans to enroll 20 additional patients, focusing on those experiencing higher levels of pain.<figure class="image"><a href="https://stocktwits.com/symbol/AMIX"><img style="aspect-ratio:1285/291;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_28_103029_e257a3d1ef.png" alt="Screenshot 2024-10-28 103029.png" width="1285" height="291"></a><figcaption>Autonomix Medical's sentiment meter as of 10:30 a.m. ET on Oct. 28, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits shot up to ‘extremely bullish’ (89/100) from ‘neutral’ a day ago accompanied by ‘extremely high’ (92/100) chatter.&nbsp;On Thursday last week, Autonomix completed a 1-for-20 reverse stock split. Every 20 shares were combined into one share, reducing the total number of outstanding shares from about 23 million to around 1.15 million.Autonomix’s stock has been struggling since its listing in February, earlier this year. It saw highs of $152 and has since lost 86% of its value.For updates and corrections email newsroom@stocktwits.com.Read more:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/biontech-stock-falls-after-fda-concerns/cJ22FLsRIs">BioNTech Stock Dips On FDA Concerns Over Cancer Drug Trial: Retail Response Mixed</a>

Autonomix Medical reported positive preliminary results from its ongoing proof-of-concept human clinical trial. | Source: Pexels

Autonomix’s Stock Rallies on Strong Trial Results: Retail Sentiment Soars

Autonomix’s stock has been struggling since its listing in February, earlier this year. It saw highs of $152 and has since lost 86% of its value. Monday’s surge in share price comes after the company completed a 1-for-20 reverse stock split on Thursday.

This account has been verified as an official AMIX representative.

Verified Account

Autonomix Medical

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in The Woodlands, TX.

Autonomix Medical Inc.

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

AMIX
Autonomix Medical Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AMIX News

AMIXAutonomix Medical Inc.